<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2025-06-30</publicationDate>
    
        <volume>18</volume>
        <issue>2</issue>

 
    <startPage>1512</startPage>
    <endPage>1523</endPage>

	 
      <doi>10.13005/bpj/3189</doi>
        <publisherRecordId>66554</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Impact of a Low-carb Diet on Obese Patients with Type 2 Diabetes Based on the Intermittent Fasting Regimen</title>

    <authors>
	 


      <author>
       <name>Driton Sopa</name>

 
		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Antonino De Lorenzo</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Laura Di Renzo</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Division of Clinical Nutrition and Nutrigenomics, Rome, Italy</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Clinical Biochemistry, University Clinical Center of Kosovo, Pristina, Kosovo</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Individuals with DM2 were the subjects of this study. The nutritional intervention was made according to the IF food regime with a 6-hour feeding window of 24 hours, according to the low-calorie, low-carb diet (IF 6/24-LCD). Three checkpoints were used: phase T0, which was before to the intervention's commencement; phase T1, which was four weeks after the start of the intervention; and phase T2, which was the concluding phase, which was eight weeks after the intervention. The average results of the laboratory tests for TG/HDL ratio 3.23 ±0.36, Homa-IR 6.99±1.37, HbA1c 8.19± 1.21, and glycemia were 9.02± 1.78.In T2, the average weight loss based on BMI was 29.60±3.85 (p &gt; 0.032), or a -9.4 ∆% percentage difference from T0. The average W/H-ratio was 0.98±0.04 to 0.957±0.02 (p &gt; 0.005). The TG/HDL ratio ranged from 3.23±0.36 to 1.20±0.36 on average (p &gt; 0.007).  (P=0.036) HbA1c from 8.19±1.21 to 6.99±1.23. While ketonuria was found in the urine in both control phases T1 and T2, at 1.84± 0.81 mmol/L and 1.75±0.17 mmol/L, respectively, the presence of ketones in the urine was not observed in the T0 phase (0,195±0.07 mmol/L). The study's BMI/ketone correlation was negative, indicating that the nutritional intervention was beneficial based on IF-LCD. This is because the metabolic shift during lipolysis causes fat mass to decrease. It also resulted in a positive correlation between TG/HDL-ratio after nutritional intervention. To our knowledge, this is the first study of its kind conducted in Kosovo, offering novel insights for localized diabetes management strategies.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol18no2/impact-of-a-low-carb-diet-on-obese-patients-with-type-2-diabetes-based-on-the-intermittent-fasting-regimen/</fullTextUrl>

<keywords language="eng">

      
        <keyword>DM2</keyword>
      

      
        <keyword> Insulin resistance</keyword>
      

      
        <keyword> Intermittent fasting</keyword>
      

      
        <keyword> Low carbs diet</keyword>
      

      
        <keyword> Metabolic syndrome</keyword>
      

      
        <keyword> Obesity</keyword>
      
</keywords>
  </record>
</records>